Multimorbidity in Patients with Chronic Liver Disease: A Population-Based Study in the EpiChron Cohort, Spain DOI Open Access
Aída Moreno-Juste, Beatriz Poblador‐Plou,

Clara Laguna-Berna

et al.

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(23), P. 7198 - 7198

Published: Nov. 27, 2024

Background/Objectives: Chronic liver disease (CLD) is highly relevant in clinical practice due to its increasing incidence and associated mortality. We aimed exhaustively characterize the multimorbidity of patients with CLD. Methods: This a retrospective observational study aged 18 years older diagnosis CLD 2015 EpiChron Cohort (Spain). analyzed prevalence comorbidities according sex age, conducted logistic regression analysis as independent variable each dependent variables obtain odds ratios (OR) adjusted for age sex, performed an exploratory factor identify presence patterns. Results: A total 6836 adults had (mean 61.6 years; 62.5% women), average 13 co-existing chronic conditions. Arterial hypertension, lipid metabolism disorders, diabetes, obesity, musculoskeletal diseases were most frequent diseases. From list 110 conditions analyzed, 75 systematically CLD, including (OR, 95% confidence interval) pancreatitis (41.2, 33.5–50.6) inherited metabolic disorders (14.9, 11.8–18.8). Three patterns identified both men women, cardiovascular, metabolic-geriatric, mental-substance use, some differences by sex. Conclusions: Multimorbidity norm Our results reveal that comprehensive integral approach based on person-centered care, which should take into account their entire spectrum multimorbidity, necessary during care this type patient practice.

Language: Английский

The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review DOI Open Access
Maria Rosaria Paravati, Giuseppe Guido Maria Scarlata, Maja Milanović

et al.

Hepatoma Research, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 14, 2024

Hepatocellular carcinoma (HCC) ranks as the third leading cause of cancer-related deaths worldwide. It presents a significant and rising global health challenge due to its complex development, high mortality rate, poor prognosis. The primary treatment methods include chemotherapy, radiotherapy, surgery, yet each is associated with severe side effects. While combination therapies can enhance outcomes, they also tend amplify adverse For this reason, prevention HCC has major impact on world health. Current knowledge indicates that healthy lifestyle combined diet an excellent preventive strategy. In respect, Mediterranean represents valid strategy widely recognized by scientific community. Its effectiveness proven presence several polyphenols in main foods, including quercetin, luteolin, myricetin, kaempferol. These are present different functional foods show anticancer activity. This narrative review aims assess anti-HCC activity these characterize diet.

Language: Английский

Citations

1

Sarcopenia and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review DOI Creative Commons
Ludovico Abenavoli,

Michael Statsenko,

Giuseppe Guido Maria Scarlata

et al.

Livers, Journal Year: 2024, Volume and Issue: 4(4), P. 495 - 506

Published: Sept. 30, 2024

The primary objective of modern medicine is to extend human life expectancy. Currently, the majority hospital patients across various clinical settings are elderly or advanced-age individuals, often with multiple comorbidities and age-related alterations in peripheral tissues. One such alteration sarcopenia, a progressive decline muscle mass, strength, function, which significantly increases risk disability mortality older adults. Sarcopenia associated numerous adverse outcomes, its underlying mechanisms subject ongoing research. This narrative review discusses epidemiology, pathophysiology, diagnostic criteria for sarcopenia. It also examines connections between sarcopenia metabolic dysfunction-associated steatotic liver disease (MASLD), highlighting potential treatment approaches coexistence these two pathologies.

Language: Английский

Citations

0

Exploring the role of fatty acid esters of hydroxy fatty acids in metabolic dysfunction-associated steatotic liver disease in morbidly obese women DOI Creative Commons
Laia Bertran, Elena Cristina Rusu, Carmen Aguilar

et al.

Digestive and Liver Disease, Journal Year: 2024, Volume and Issue: unknown

Published: Nov. 1, 2024

Fatty acid esters of hydroxy fatty acids (FAHFAs) present potential beneficial effects that could offer valuable insights into metabolic and inflammatory diseases. However, few FAHFAs have been studied, their role is unclear.

Language: Английский

Citations

0

Multimorbidity in Patients with Chronic Liver Disease: A Population-Based Study in the EpiChron Cohort, Spain DOI Open Access
Aída Moreno-Juste, Beatriz Poblador‐Plou,

Clara Laguna-Berna

et al.

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(23), P. 7198 - 7198

Published: Nov. 27, 2024

Background/Objectives: Chronic liver disease (CLD) is highly relevant in clinical practice due to its increasing incidence and associated mortality. We aimed exhaustively characterize the multimorbidity of patients with CLD. Methods: This a retrospective observational study aged 18 years older diagnosis CLD 2015 EpiChron Cohort (Spain). analyzed prevalence comorbidities according sex age, conducted logistic regression analysis as independent variable each dependent variables obtain odds ratios (OR) adjusted for age sex, performed an exploratory factor identify presence patterns. Results: A total 6836 adults had (mean 61.6 years; 62.5% women), average 13 co-existing chronic conditions. Arterial hypertension, lipid metabolism disorders, diabetes, obesity, musculoskeletal diseases were most frequent diseases. From list 110 conditions analyzed, 75 systematically CLD, including (OR, 95% confidence interval) pancreatitis (41.2, 33.5–50.6) inherited metabolic disorders (14.9, 11.8–18.8). Three patterns identified both men women, cardiovascular, metabolic-geriatric, mental-substance use, some differences by sex. Conclusions: Multimorbidity norm Our results reveal that comprehensive integral approach based on person-centered care, which should take into account their entire spectrum multimorbidity, necessary during care this type patient practice.

Language: Английский

Citations

0